Alerts will be sent to your verified email
Verify Email
BACPHAR
|
Bacil Pharma
|
Guj. Inject (Kerala)
|
Vista Pharma
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
-69.0 % | 1.55 % | -9.01 % |
|
5yr average Equity Multiplier
|
1.36 | 0.11 | 1.42 |
|
5yr Average Asset Turnover Ratio
|
0.0 | 0.45 | 0.08 |
|
5yr Avg Net Profit Margin
|
0.0 | -175.28 % | -205.63 % |
|
Price to Book
|
1.86 | 5.12 | 1.21 |
|
P/E
|
76.62 | 122.82 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
0.0 | -14.62 Days | 124.89 Days |
|
Inventory Days
|
0.0 | 38.61 Days | 3040.44 Days |
|
Days Receivable
|
0.0 | 0.0 | 137.33 Days |
|
Days Payable
|
0.0 | 156.02 Days | 1845.08 Days |
|
5yr Average Interest Coverage Ratio
|
-943.72 | 298.1 | -2.88 |
|
5yr Avg ROCE
|
-75.56 % | 2.0 % | -8.17 % |
|
5yr Avg Operating Profit Margin
|
0.0 | -279.73 % | -192.46 % |
|
5 yr average Debt to Equity
|
0.05 | -0.62 | 0.26 |
|
5yr CAGR Net Profit
|
n/a | n/a | 19.73 % |
|
5yr Average Return on Assets
|
-70.2 % | -116.01 % | -6.49 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
0.08 % | 0.0 | 21.19 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-42.59 % | 0.0 | -14.25 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | -0.02 % |
|
Bacil Pharma
|
Guj. Inject (Kerala)
|
Vista Pharma
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|